SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,104,182,260 |
| Positions | 58 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| LIQUIDIA CORPORATION | LQDA | COM NEW | $195,139,175 | 2,447,500 |
| ETON PHARMACEUTICALS INC | ETON | COM | $103,532,000 | 2,860,000 |
| HARROW INC | HROW | COM | $101,928,000 | 2,400,000 |
| DISC MEDICINE INC | IRON | COM | $62,534,700 | 855,000 |
| UROGEN PHARMA LTD | URGN | COM | $52,991,853 | 1,439,996 |
| APOGEE THERAPEUTICS INC | APGE | COM | $51,764,700 | 390,000 |
| MEIRAGTX HLDGS PLC | MGTX | COM | $47,960,500 | 3,550,000 |
| SOL-GEL TECHNOLOGIES LTD | Unresolved | SHS NEW | $37,070,000 | 500,000 |
| REZOLUTE INC | RZLT | COM NEW | $32,760,000 | 6,300,000 |
| TG THERAPEUTICS INC | TGTX | COM | $29,392,900 | 535,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.